Laura Morgan
Authored Items
November 2022 – Lung Cancer
This article highlights the new therapies targeting a specific biomarker that have become available for patients with non–small-cell lung cancer in the past 3 years, significantly improving patient survival.
November 2021 – Lung Cancer
For most patients with cancer, the mRNA COVID-19 vaccines are safe and effective. This article explains the results of the first study that evaluated the safety and effectiveness of the mRNA vaccines in patients with solid cancers, such as lung, breast, or prostate cancer.
May 2018 – Cancer Biomarkers and Molecular Testing
The terms genetics and genomics are often used interchangeably in relation to cancer, but they refer to different things and are becoming very important in cancer treatment.
December 2017 Vol 3 No 6
Unlike many types of cancers, the number of new cases of liver cancer, specifically hepatocellular carcinoma—the most common type of liver cancer—is increasing in the US. Read about the pressures, including the unmet needs, of caregivers of those affected by liver cancer.
June 2017 – Cancer Immunotherapy
Take a look at the 5 new promising immunotherapies approved by the FDA for bladder cancer after decades of no new treatment options for this type of cancer.
December 2016 Vol 2 No 6
Myeloproliferative neoplasms, better known as MPNs, are rare and chronic type of blood cancers that develop when the body makes too many red blood cells, white blood cells, or platelets. MPNs are a type of blood cancer that gets worse with time, and because they are chronic, they can last for many years.
December 2016 Vol 2 No 6
It’s quite common for patients with cancer to form strong bonds with their oncologists. But it’s not often that patients form connections with researchers, the very scientists who develop cancer therapies that help patients, especially patients facing cancer.
October 2016 Vol 2 No 5
Lung cancer is the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, approximately 224,390 people will be diagnosed with lung cancer in 2016, and more than 158,000 patients will die from this disease. Smoking is the major risk factor for lung cancer–80% of lung cancer deaths are related to smoking.
October 2016 Vol 2 No 5
Dorothy won a gold medal at the 1976 Winter Olympics in Austria, read about her fight–off the ice–with breast cancer.
August 2016 Vol 2 No 4
The American Cancer Society estimates that 10,380 children under age 15 and about 5,000 teens aged 15 to 19 will be diagnosed with cancer this year in the United States. The rate of children surviving cancer for 5 years or more is growing thanks to improved treatment, but so is the rate of children and teens who are diagnosed with cancer.
August 2016 Vol 2 No 4
Bladder cancer is the fourth most common cancer type in men, but many new therapies are now being used. Here’s an excellent overview of the risk factors, symptoms, and treatments.
August 2016 Vol 2 No 4
It’s hard to believe that Kirk Smith, the 54-year-old owner of an advertising company, a triathlete, and a runner for the past 15 years or so, has lung cancer.
June 2016 Vol 2 No 3
Lung cancer is the second most common cancer in men and women. Approximately 224,390 new cases of lung cancer will be diagnosed in 2016. Lung cancer kills more Americans each year than any other cancer.
April 2016 Vol 2 No 2
Kidney cancers are among the 10 most common cancers in men and women in the United States. According to the American Cancer Society, about 62,700 new cases of kidney cancer will be diagnosed in the United States in 2016, and 14,240 people will die from the disease.
April 2016 Vol 2 No 2
On February 11, 2016, the multiple myeloma community lost Pat Killingsworth, one of its most loved and influential patient advocates. Pat was diagnosed with multiple myeloma in April 2007, at age 51.
Last modified: May 31, 2017